Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
American journal of cardiology
| American journal of cardiology |
| Pubbl/distr/stampa | New York, : Elsevier |
| Disciplina | 616.105 |
| ISSN | 0002-9149 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Note periodicità | Quindicinale |
| Record Nr. | UNINA-990008891240403321 |
| New York, : Elsevier | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiology : the journal of vascular diseases
| Angiology : the journal of vascular diseases |
| Pubbl/distr/stampa | Glen Head, N.Y., : Westminster Publications |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.105 |
| Soggetto topico |
Blood-vessels - Diseases
Angiography Vascular Diseases Blood Vessels Cardiology Vaisseaux sanguins - Maladies Angiographie Vaisseaux sanguins Cardiologie |
| Soggetto genere / forma |
Periodical
Periodicals. periodicals. Périodiques. |
| ISSN | 1940-1574 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996251302503316 |
| Glen Head, N.Y., : Westminster Publications | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Angiology
| Angiology |
| Pubbl/distr/stampa | Baltimore, : Westminster Publications |
| Disciplina | 616.105 |
| ISSN | 0003-3197 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Note periodicità | Mensile |
| Record Nr. | UNINA-990008893790403321 |
| Baltimore, : Westminster Publications | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiology : the journal of vascular diseases
| Angiology : the journal of vascular diseases |
| Pubbl/distr/stampa | Glen Head, N.Y., : Westminster Publications |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.105 |
| Soggetto topico |
Blood-vessels - Diseases
Angiography Vascular Diseases Blood Vessels Cardiology Vaisseaux sanguins - Maladies Angiographie Vaisseaux sanguins Cardiologie |
| Soggetto genere / forma |
Periodical
Periodicals. periodicals. Périodiques. |
| ISSN | 1940-1574 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910154544803321 |
| Glen Head, N.Y., : Westminster Publications | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Avoiding heart attacks and strokes [[electronic resource] ] : don't be a victim - protect yourself
| Avoiding heart attacks and strokes [[electronic resource] ] : don't be a victim - protect yourself |
| Pubbl/distr/stampa | Geneva, : World Health Organization, c2005 |
| Descrizione fisica | 1 online resource (46 p.) |
| Disciplina | 616.105 |
| Soggetto topico |
Myocardial infarction - Prevention
Cerebrovascular disease - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-26869-7
9786610268696 1-4237-4757-7 92-4-068447-6 92-4-068010-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Why you should read this booklet; Key messages; Part 1. What you should know; 1. Understanding heart attacks and strokes; 2. Preventing heart attacks and strokes; 3. What are the signs of a heart attack and what should you do?; 4. What are the signs of stroke and what should you do?; 5. Other heart diseases; Part 2. What you can do; 6. Stop using tobacco; 7. Improve your diet; 8. Stay active and control your weight; 9. Reduce high blood pressure; 10. Reduce high blood sugar; 11. Reduce high blood fat levels; Annex. Medicines for treating and managing heart attacks and strokes
Explanation of terms used in this bookletContributors |
| Record Nr. | UNINA-9910450414403321 |
| Geneva, : World Health Organization, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Avoiding heart attacks and strokes [[electronic resource] ] : don't be a victim - protect yourself
| Avoiding heart attacks and strokes [[electronic resource] ] : don't be a victim - protect yourself |
| Pubbl/distr/stampa | Geneva, : World Health Organization, c2005 |
| Descrizione fisica | 1 online resource (46 p.) |
| Disciplina | 616.105 |
| Soggetto topico |
Myocardial infarction - Prevention
Cerebrovascular disease - Prevention |
| ISBN |
1-280-26869-7
9786610268696 1-4237-4757-7 92-4-068447-6 92-4-068010-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Why you should read this booklet; Key messages; Part 1. What you should know; 1. Understanding heart attacks and strokes; 2. Preventing heart attacks and strokes; 3. What are the signs of a heart attack and what should you do?; 4. What are the signs of stroke and what should you do?; 5. Other heart diseases; Part 2. What you can do; 6. Stop using tobacco; 7. Improve your diet; 8. Stay active and control your weight; 9. Reduce high blood pressure; 10. Reduce high blood sugar; 11. Reduce high blood fat levels; Annex. Medicines for treating and managing heart attacks and strokes
Explanation of terms used in this bookletContributors |
| Record Nr. | UNINA-9910783715703321 |
| Geneva, : World Health Organization, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Avoiding heart attacks and strokes : don't be a victim - protect yourself
| Avoiding heart attacks and strokes : don't be a victim - protect yourself |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, c2005 |
| Descrizione fisica | 1 online resource (46 p.) |
| Disciplina | 616.105 |
| Soggetto topico |
Myocardial infarction - Prevention
Cerebrovascular disease - Prevention |
| ISBN |
1-280-26869-7
9786610268696 1-4237-4757-7 92-4-068447-6 92-4-068010-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Why you should read this booklet; Key messages; Part 1. What you should know; 1. Understanding heart attacks and strokes; 2. Preventing heart attacks and strokes; 3. What are the signs of a heart attack and what should you do?; 4. What are the signs of stroke and what should you do?; 5. Other heart diseases; Part 2. What you can do; 6. Stop using tobacco; 7. Improve your diet; 8. Stay active and control your weight; 9. Reduce high blood pressure; 10. Reduce high blood sugar; 11. Reduce high blood fat levels; Annex. Medicines for treating and managing heart attacks and strokes
Explanation of terms used in this bookletContributors |
| Record Nr. | UNINA-9910811111503321 |
| Geneva, : World Health Organization, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiorespiratory Fitness in Cardiometabolic Diseases : Prevention and Management in Clinical Practice / / edited by Peter Kokkinos, Puneet Narayan
| Cardiorespiratory Fitness in Cardiometabolic Diseases : Prevention and Management in Clinical Practice / / edited by Peter Kokkinos, Puneet Narayan |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (442 pages) |
| Disciplina |
616.105
616.1 |
| Soggetto topico |
Cardiology
Health promotion Health Promotion and Disease Prevention |
| ISBN | 3-030-04816-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1 - Physical Activity, Cardiorespiratory Fitness and Health: A Historical Perspective - Peter Kokkinos and Jonathan Myers -- Chapter 2 - Exercise, Gene Regulation and Cardiometabolic Disease - Mark A. Chapman and Carl Johan Sundberg -- Chapter 3 - Exercise and the Mitochondria - Eva-Karin Gidlund -- Chapter 4 - Effects of Exercise on Adult Stem Cells - Nabanita Kundu, Cleyton C. Domingues and Sabyasachi Sen -- Chapter 5 - Exercise Metabolism in Health and Disease - Anastassios Philippou, Costas Chryssanthopοulos, Maria Maridaki, George Dimitriadis and Michael Koutsilieris -- Chapter 6 - Exercise and the Endothelium - Joshua C. Tremblay and Kyra E. Pyke -- Chapter 7 - Exertion-Related Acute Cardiovascular Events: Pathophysiologic Considerations, Risk Modulators, and Prophylactic Interventions - Barry A. Franklin and Peter Kokkinos -- Chapter 8 - Exercise and Blood Pressure Control in Hypertension - Hayley V. MacDonald and Linda S. Pescatello -- Chapter 9 - Role of Physical Activity, Exercise and Cardiorespiratory Fitness in Management of Resistant Hypertension - Puneet Narayan and Anubhav Kumar -- Chapter 10 - Physical Activity, Blood Pressure and Cardiac Structure and Function - Peter Kokkinos -- Chapter 11 - Physical Activity, Cardiorespiratory Fitness, and the Diabetes Spectrum - Eric S. Nylén and Peter Kokkinos -- Chapter 12 - Cardiorespiratory Fitness, Physical Activity and Metabolic Syndrome - Eric S. Nylén, Shruti M. Gandhi and Raj Lakshman -- Chapter 13 - Exercise Interventions in Patients with Diabetes and Peripheral Artery Disease - Mary M. McDermott -- Chapter 14 - Physical Activity, Cardiorespiratory Fitness, and Obesity - Louise de Lannoy and Robert Ross -- Chapter 15 - The Obesity Paradox and Cardiorespiratory Fitness - Michelle Phuong Nguyen, Sergey Kachur and Carl J. Lavie -- Chapter 16 - Physical Activity, Exercise, and Lipids and Lipoproteins - J. Larry Durstine, Elizabeth Anderson, Ryan R. Porter and Xuewen Wang -- Chapter 17 - Physical Activity, Fitness and Coronary Heart Disease - Michael J. LaMonte -- Chapter 18 - Physical Activity and Cardiorespiratory Fitness in Heart Failure - Jonathan Myers -- Chapter 19 - Cardiorespiratory Fitness, Physical Activity and Stroke - Steven P. Hooker and Michelle N. McDonnell -- Chapter 20 - Cardiorespiratory Fitness, Physical Activity and Incidence of Atrial Fibrillation - Apostolos Tsimploulis, Andreas Pittaras and Charles Faselis -- Chapter 21 - Chronic Kidney Disease and Physical Activity - Anubhav Kumar, Puneet Narayan and Peter Kokkinos -- Chapter 22 - Physical Activity, Fitness and Sexual Dysfunction - Konstantinos P. Imprialos, Konstantinos Stavropoulos and Michael Doumas -- Chapter 23 - Cardiorespiratory Fitness in the Context of Cardiac Rehabilitation - Jonathan K. Ehrman -- Chapter 24 - Physical Activity and Cardiometabolic Health Benefits in Children - Konstantinos D. Tambalis and Labros S. Sidossis -- Chapter 25 - Association Between Cardiorespiratory Fitness and Health Care Costs - Jonathan Myers. |
| Record Nr. | UNINA-9910337474503321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiosource review journal
| Cardiosource review journal |
| Pubbl/distr/stampa | New York, : Elsevier |
| Disciplina | 616.105 |
| ISSN | 1556-8571 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Note periodicità | Mensile |
| Record Nr. | UNINA-990008936780403321 |
| New York, : Elsevier | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular risk assessment in primary prevention / / edited by Michael D. Shapiro
| Cardiovascular risk assessment in primary prevention / / edited by Michael D. Shapiro |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (507 pages) |
| Disciplina | 616.105 |
| Collana | Contemporary Cardiology |
| Soggetto topico | Internal medicine |
| ISBN |
9783030988241
9783030988234 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Contributors -- Part I: Global Approaches to Risk Assessment -- Chapter 1: Cardiovascular Risk Assessment in Primary Prevention -- Introduction -- Importance of Global Cardiovascular Risk Assessment -- Global CVD Risk Assessment in Clinical Practice -- Risk Calculators to Estimate CVD Risk -- Role of Risk Enhancers for Refining and Personalizing Risk Assessment -- Cardiovascular Risk Biomarkers -- Lipid Parameters -- Inflammatory Marker: - hs-CRP -- Future Directions -- Risk Stratification for Secondary ASCVD Prevention -- Tools to Screen for Subclinical Atherosclerosis -- Risk Reclassification Using Coronary Artery Calcium Scoring -- Carotid Plaque -- Ankle-Brachial Index (ABI) -- Assessment of Lifetime ASCVD Risk -- Risk Assessment in the Context of Shared Decision-Making -- Conclusion -- References -- Chapter 2: Global Approaches to Risk Assessment: The US Guidelines -- Introduction -- US Guideline Recommendations -- Risk-Enhancing Factors -- Coronary Artery Calcium Score -- Lifetime Risk Assessment -- Limitations of Current Approaches to Risk Assessment -- Considerations for Enhancing Cardiovascular Risk Assessment -- Larger and More Diverse Contemporary Epidemiological Cohorts -- Precision Medicine -- Social Determinants of Health -- Conclusion -- References -- Chapter 3: European Guidelines for Risk Assessment in the Primary Prevention of Cardiovascular Disease -- Introduction -- Current European Recommendations for Risk Assessment in CVD Prevention -- The New SCORE2 Risk Estimator -- Other Risk Scores Endorsed in the 2021 ESC Guideline -- SCORE-OP and Other Risk Algorithms Developed by ESC -- ADVANCE Risk Score Among Primary Prevention Diabetics (Endorsed but Not Developed by ESC) -- SMART-REACH Risk Score for Secondary Prevention Adults (Endorsed but Not Developed by ESC).
LIVE-CVD Score for Primary Prevention Adults Aged < -- 50/> -- 70 Years (Endorsed but Not Developed by ESC) -- ESC 2021 Recommendation for the Use of CVD Risk Estimates in Risk Factor Management -- Cholesterol Measurement and Management -- Hypertension -- Diabetes Mellitus -- Chronic Kidney Disease -- Advice Regarding Antithrombotic Therapy -- Summary -- References -- Part II: Traditional Risk Factors -- Chapter 4: Hypercholesterolemia -- The Role of Low-Density Lipoprotein Cholesterol in the Development and Progression of Cardiovascular Disease -- Primary Prevention in High-Risk Groups -- Genetic Disorders/Familial Hypercholesterolemia -- Diabetes and the Metabolic Syndrome -- Conclusion/Future Directions -- References -- Chapter 5: Blood Pressure Control in Primary Care -- Epidemiology -- Guideline Definitions and Treatment Goals -- Prevalence, Treatment, and Control in Primary Care -- BP Control and Disabling Conditions -- Framework -- Implications of an Aging Population on Treatment Approach -- Steps in BP Management -- Measure -- Plan -- Treat -- Monitor -- Implementing This Framework into Primary Care -- Conclusions -- References -- Chapter 6: Cardiovascular Risk Assessment in Metabolic Syndrome and Diabetes -- Introduction -- Epidemiology of Metabolic Syndrome, Diabetes, and Cardiovascular Disease -- Global Cardiovascular Risk Assessment in Metabolic Syndrome and Diabetes -- Role of Subclinical Atherosclerosis in Risk Stratification for Metabolic Syndrome and Diabetes -- Risk Prediction Strategies in Metabolic Syndrome and Diabetes -- Evidence for Multiple Risk Factor Control to Reduce Cardiovascular Risk in Metabolic Syndrome and Diabetes -- Conclusions -- References -- Chapter 7: Primary Prevention: Smoking -- Introduction -- Smoking and Cardiovascular Risk -- Pathophysiology -- Smoking Cessation -- Behavioral Interventions. Pharmacological Therapies -- Nicotine Replacement -- Bupropion -- Varenicline -- Second-Line Therapies -- Opportunities for Intervention -- References -- Chapter 8: At the Heart of the Matter: Obesity and Its Interplay with Preventive Cardiology -- Scope of Obesity -- Links Between Obesity and Cardiovascular Disease -- Assessment of the Patient with Obesity -- History -- Physical Exam -- Review of Medications -- Obesity-Related Complications: Metabolic, Mechanical, and Psychosocial -- Metabolic Complications -- Mechanical -- Psychosocial -- Treatment of the Patient with Obesity -- Behavior Modifications -- Dietary Patterns -- Physical Activity -- Sleep -- Stress Management -- Antiobesity Pharmacotherapy -- Phentermine -- Phentermine/Topiramate ER (Qsymia) -- Naltrexone/Bupropion (Contrave) -- Liraglutide 3.0 mg (Saxenda) -- Bariatric Surgery -- Challenges and Barriers of Obesity Treatment -- Conclusion -- References -- Part III: Risk Enhancers -- Chapter 9: Family History of Premature Atherosclerotic Cardiovascular Disease -- Introduction -- Epidemiology of Family History of Premature ASCVD -- Prevalence of Family History of Premature Cardiovascular Disease -- Family History of Premature Cardiovascular Disease and Cardiovascular Risk -- Pathophysiology of Familial Cardiovascular Risk -- Genetic Determinants of Familial Cardiovascular Risk -- Clustering of Cardiovascular Risk Factors and Familial Cardiovascular Risk -- Family History of Premature ASCVD in Clinical Practice -- Accuracy of Family History of Premature Cardiovascular Disease -- Family History of Premature Cardiovascular Disease and Risk Prediction -- Clinical Applications of Family History of Premature Cardiovascular Disease -- Current Utilization of Family History of Premature Cardiovascular Disease. Ethical, Legal, and Social Implications of Collecting Family History of Premature Cardiovascular Disease -- Practical Considerations in Obtaining a Family History -- Conclusion -- References -- Chapter 10: Primary Prevention and Cardiovascular Risk Assessment in Women -- Sex, Gender, and Genetic Differences in CVD -- Cardiovascular Risk Factors in Women -- Traditional CVD Risk Factors and Their Impact on Women -- Age -- Family History -- Hypertension -- Diabetes -- Dyslipidemia -- Cigarette Smoking -- Physical Activity/Physical Fitness -- Metabolic Syndrome -- Obesity -- High-Sensitivity C-Reactive Protein -- Sleep Apnea -- Sex-Specific Risk Factors -- Age of Menarche -- Pregnancy-Associated Conditions -- Eclampsia, Preeclampsia, and Gestational Hypertension -- Gestational Diabetes -- Preterm Delivery -- Small-for-Gestational-Age Infant -- Miscarriages/Stillbirths -- Assisted Reproductive Therapies -- Polycystic Ovary Syndrome -- Functional Hypothalamic Amenorrhea -- Premature Menopause and Premature Ovarian Insufficiency -- Reproductive Hormones -- Oral Contraceptive Therapy -- Postmenopausal Hormone Therapy -- Sex-Predominant CVD Risk Factors -- Autoimmune Disorders -- Breast Arterial Calcification -- Breast Cancer Therapy -- Cardiovascular Disease Risk Assessment -- References -- Chapter 11: Ethnic Factors in the Assessment of Cardiovascular Risk for Primary Prevention -- Introduction -- Ethnic Groups at High Risk for Cardiovascular Disease -- Hispanic/Latino Americans -- African American/Black Individuals -- South Asians -- Native Americans (American Indians/Alaska Natives) -- East Asians -- Overview of Patient Management (Table 11.5) -- Future Directions (Table 11.6) -- Conclusions -- References -- Chapter 12: Triglyceride-Rich Lipoproteins -- Introduction -- Epidemiology of Hypertriglyceridemia -- Hypertriglyceridemia as a Risk Enhancer. Metabolism and Atherogenic Potential of Triglyceride-Rich Lipoproteins -- Biochemical/Regulatory Pathways of TGs and Lipoproteins -- Metabolic Consequences and Impact of TRLs on ASCVD -- Landmark Clinical Trials of TRLs and ASCVD -- REDUCE-IT -- STRENGTH -- Why Were Results of REDUCE-IT and STRENGTH Discrepant? -- PROMINENT -- Current Treatments for HTG -- Lifestyle Modifications -- Traditional TG-Lowering Therapies -- Omega-3 Fatty Acids -- Novel and Future Therapies -- Apo-CIII Inhibition -- Angiopoietin-Like Protein 3 (ANGPTL3) Inhibition -- Gemcabene -- Fibroblast Growth Factor 21 (FGF21) -- Current Recommendations -- Summary -- References -- Chapter 13: Inflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: A New Focus on Prevention -- Introduction -- Inflammation in the Initiation and Propagation of Atherosclerosis -- Source of Chronic Inflammation in Normal Aging: Aging as an Inflammatory "Disease" -- Atherosclerosis in Specific Inflammatory Conditions -- Incorporation of Inflammatory Conditions into Risk Assessment -- Obesity and Metabolic Syndrome -- Rheumatoid Arthritis -- Systemic Lupus Erythematosus -- Psoriasis -- Human Immunodeficiency Virus (HIV) -- Assessment of Inflammation: Role of Markers and Imaging -- Inflammatory Markers -- hsCRP -- Monocytes and Neutrophils -- Serum Amyloid A -- GlycA -- Imaging -- Nuclear Imaging -- Coronary CT Angiography -- Magnetic Resonance Imaging -- Therapeutic Targeting of Inflammation for Cardiovascular Risk Reduction -- IL-1β Inhibition -- IL-6 Inhibition -- Colchicine -- Low-Dose Methotrexate -- Nonsteroidal Anti-inflammatory Drugs -- Conclusions -- References -- Chapter 14: Chronic Kidney Disease Is a Risk Enhancer for Cardiovascular Diseases -- Introduction -- Epidemiology -- Definition of Chronic Kidney Disease -- Prevalence of Chronic Kidney Disease. Prevalence of Cardiovascular Disease in Chronic Kidney Disease. |
| Record Nr. | UNINA-9910574051403321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
